Naproxen
Product Images NDC 31722-338

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 31722-338). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

35bc8579-figure-01 (35bc8579 Figure 01)

Chemical structure of naproxen shown with molecular formula C14H14O3 and molecular weight 230.26. The structure includes the carboxylic acid group (R=COOH) and characteristic naphthalene and methoxy functional groups.*

FDA Label Image

35bc8579-figure-02 (35bc8579 Figure 02)

Naproxen delayed-release tablets, USP 500 mg by Camber Pharmaceuticals. The label includes the NDC code 31722-339-01 and specifies a package size of 100 tablets. It indicates the product is Rx only and instructs pharmacists to dispense a medication guide. Storage instructions and manufacturer details are also present.*

FDA Label Image

35bc8579-figure-03 (35bc8579 Figure 03)

Label for Naproxen Delayed-release Tablets, USP 375 mg by Camber Pharmaceuticals. The label states the product contains 100 tablets. It includes storage instructions and notes that the package is child-resistant. Manufactured by InvaGen Pharmaceuticals, Inc. with addresses for both manufacturers listed. The barcode and NDC 31722-338-01 are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.